Press Releases Tyra Biosciences, Inc.

Equities

TYRA

US90240B1061

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
18.26 ^USD	-4.40%		+5.24%	+31.84%

13/05	Oppenheimer Adjusts Tyra Biosciences Price Target to $28 From $25, Maintains Outperform Rating	MT
09/05	Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights	10/05	PR
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors	08/05	PR
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights	20/03	PR
Tyra Biosciences to Present at Upcoming Investor Conferences	28/02	PR
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference	08/02	PR
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing	02/02	PR
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia	02/02	PR
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300	22/12	PR
Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference	09/11	PR
Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual Meetings	22/23/22	AQ
Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference	13/23/13	PR
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights	11/23/11	PR
Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia	01/23/01	PR
Tyra Biosciences to Participate in Upcoming Investor Conferences	25/23/25	PR
TYRA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/23/05	AQ
Tyra Biosciences Reports First Quarter 2023 Financial Results and Highlights	05/23/05	PR
Tyra Biosciences to Participate in Upcoming Investor Conferences	30/23/30	PR
TYRA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23/23/23	AQ
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights	23/23/23	PR
TYRA BIOSCIENCES, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)	01/23/01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Tyra Biosciences, Inc.

Equities

TYRA

US90240B1061

Press Releases

Filters